Ignite Creation Date:
2024-05-06 @ 7:28 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022029
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2023-08-15
Brief Title:
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas
Sponsor:
OncoNano Medicine Inc
Organization:
OncoNano Medicine Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-29
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-15
First Submit QC Date:
August 29 2023
Study First Post Date:
2023-09-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-03-28
Last Update Post Date Type:
ACTUAL